Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.

<h4>Purpose</h4>This study aimed to investigate whether early axial length (AL) changes in the short term after 0.125% atropine treatment could predict long-term axial elongation in children with myopia.<h4>Methods</h4>This was a prospective cohort study involving children ag...

Full description

Saved in:
Bibliographic Details
Main Authors: Zi-Rong Chen, Tsung-Yao Wan, Lan-Hsin Chuang, Chi-Chun Lai, Yih-Shiou Hwang, Yu-Kai Kuo, Ho-Min Chen, Po-Chun Chang, Hung-Chi Chen, Chun-Fu Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0327354
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849228181842690048
author Zi-Rong Chen
Tsung-Yao Wan
Lan-Hsin Chuang
Chi-Chun Lai
Yih-Shiou Hwang
Yu-Kai Kuo
Ho-Min Chen
Po-Chun Chang
Hung-Chi Chen
Chun-Fu Liu
author_facet Zi-Rong Chen
Tsung-Yao Wan
Lan-Hsin Chuang
Chi-Chun Lai
Yih-Shiou Hwang
Yu-Kai Kuo
Ho-Min Chen
Po-Chun Chang
Hung-Chi Chen
Chun-Fu Liu
author_sort Zi-Rong Chen
collection DOAJ
description <h4>Purpose</h4>This study aimed to investigate whether early axial length (AL) changes in the short term after 0.125% atropine treatment could predict long-term axial elongation in children with myopia.<h4>Methods</h4>This was a prospective cohort study involving children aged 5-15 years with myopia who were treated with 0.125% atropine for myopia control. AL was measured 1-2 months after starting treatment and then every 3 months for follow-up visits. Regression analysis was used to develop a model of AL changes with time. A generalized estimating equation (GEE) model was then used to identify correlations between the early AL changes and long-term AL changes.<h4>Results</h4>Eighty eyes of 40 patients (mean age 8.4 years) were included in the final analysis. The estimation curve of AL changes with time indicated that the AL decreased at 67 days (the turning point in the regression model) after 0.125% atropine treatment and then increased gradually with time. Univariate GEE showed that a larger AL elongation in the initial 4 months was significantly associated with AL changes at 6 months (β = 0.354, P = 0.020, 6 ~ 12 months period from baseline) and 12 months (β = 0.560, P = 0.045, 6 ~ 18 months period from baseline) after that period in all myopic eyes.<h4>Conclusions</h4>The magnitude of AL elongation in the initial 4 months of 0.125% atropine treatment correlated positively with the further half-year and one-year AL changes. Identifying these changes may be useful for controlling refractory myopia in children.
format Article
id doaj-art-c83d981b08ca43daa28f868079d8de98
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-c83d981b08ca43daa28f868079d8de982025-08-23T05:32:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01208e032735410.1371/journal.pone.0327354Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.Zi-Rong ChenTsung-Yao WanLan-Hsin ChuangChi-Chun LaiYih-Shiou HwangYu-Kai KuoHo-Min ChenPo-Chun ChangHung-Chi ChenChun-Fu Liu<h4>Purpose</h4>This study aimed to investigate whether early axial length (AL) changes in the short term after 0.125% atropine treatment could predict long-term axial elongation in children with myopia.<h4>Methods</h4>This was a prospective cohort study involving children aged 5-15 years with myopia who were treated with 0.125% atropine for myopia control. AL was measured 1-2 months after starting treatment and then every 3 months for follow-up visits. Regression analysis was used to develop a model of AL changes with time. A generalized estimating equation (GEE) model was then used to identify correlations between the early AL changes and long-term AL changes.<h4>Results</h4>Eighty eyes of 40 patients (mean age 8.4 years) were included in the final analysis. The estimation curve of AL changes with time indicated that the AL decreased at 67 days (the turning point in the regression model) after 0.125% atropine treatment and then increased gradually with time. Univariate GEE showed that a larger AL elongation in the initial 4 months was significantly associated with AL changes at 6 months (β = 0.354, P = 0.020, 6 ~ 12 months period from baseline) and 12 months (β = 0.560, P = 0.045, 6 ~ 18 months period from baseline) after that period in all myopic eyes.<h4>Conclusions</h4>The magnitude of AL elongation in the initial 4 months of 0.125% atropine treatment correlated positively with the further half-year and one-year AL changes. Identifying these changes may be useful for controlling refractory myopia in children.https://doi.org/10.1371/journal.pone.0327354
spellingShingle Zi-Rong Chen
Tsung-Yao Wan
Lan-Hsin Chuang
Chi-Chun Lai
Yih-Shiou Hwang
Yu-Kai Kuo
Ho-Min Chen
Po-Chun Chang
Hung-Chi Chen
Chun-Fu Liu
Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.
PLoS ONE
title Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.
title_full Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.
title_fullStr Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.
title_full_unstemmed Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.
title_short Early identification of the efficacy of 0.125% atropine treatment for children with Myopia: A prospective pilot study.
title_sort early identification of the efficacy of 0 125 atropine treatment for children with myopia a prospective pilot study
url https://doi.org/10.1371/journal.pone.0327354
work_keys_str_mv AT zirongchen earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy
AT tsungyaowan earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy
AT lanhsinchuang earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy
AT chichunlai earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy
AT yihshiouhwang earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy
AT yukaikuo earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy
AT hominchen earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy
AT pochunchang earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy
AT hungchichen earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy
AT chunfuliu earlyidentificationoftheefficacyof0125atropinetreatmentforchildrenwithmyopiaaprospectivepilotstudy